Ignite Creation Date:
2025-12-25 @ 12:28 AM
Ignite Modification Date:
2026-02-20 @ 6:20 PM
Study NCT ID:
NCT04085367
Status:
COMPLETED
Last Update Posted:
2022-04-01
First Post:
2019-09-09
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Multicenter Study to Assess the Efficacy and Safety of Methyl Aminolevulinate Hydrochloride (MAL) 16.8% Cream (CD06809-41) Versus Vehicle Cream for Actinic Keratosis of the Face
Sponsor:
Galderma R&D
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
RD.06.SPR.112199
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None